Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
FUJI KYUKO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%
9010 FUJI KYUKO CO., LTD. 【J-GAAP】
Earnings ReportFUJI KYUKO CO., LTD. <9010> [TSE Prime] announced its financial results after the market closed on February 4th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) increased 5.4% from the same period last year, reaching 6.90 billion yen. Progress toward the full-year plan of 8.45 billion yen was 81.8%, it was below the five-year average of 105.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 2.0% from the same period last year to 1.54 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit amounted to 2.52 billion yen, an increase of 0.3% compared to the same period last year. However, the operating profit margin decreased from 18.7% in the same period last year to 18.1%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 39,027 | 7,203 | 7,048 | 4,701 | 88.6 | 88.8 | Feb 7, 2024 | J-GAAP |
| Apr - Dec, 2024 | 39,433 | 6,683 | 6,552 | 4,387 | 82.6 | 80.6 | Feb 5, 2025 | J-GAAP |
| Apr - Dec, 2025 | 40,711 | 6,991 | 6,909 | 4,512 | 85.0 | 81.8 | Feb 4, 2026 | J-GAAP |
| YoY | +3.2% | +4.6% | +5.4% | +2.8% | +2.9% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 26,419 | 4,174 | 4,090 | 2,438 | 45.9 | 29 | May 8, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 28,246 | 4,306 | 4,065 | 2,455 | 46.2 | 30 | Nov 5, 2025 | J-GAAP |
| YoY | +6.9% | +3.2% | -0.6% | +0.7% | +0.7% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 50,701 | 8,151 | 7,936 | 4,571 | 86.1 | 26 | May 8, 2024 | J-GAAP |
| Mar, 2025 | 52,230 | 8,313 | 8,125 | 5,107 | 96.2 | 29 | May 8, 2025 | J-GAAP |
| Mar, 2026 Guidance | 54,850 | 8,750 | 8,450 | 5,300 | 99.8 | 30 | May 8, 2025 | J-GAAP |
| YoY | +5.0% | +5.3% | +4.0% | +3.8% | +3.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 13,622 | 2,544 | 2,517 | 1,718 | 32.4 | 18.7 | Feb 5, 2025 | J-GAAP |
| Jan - Mar, 2025 | 12,797 | 1,630 | 1,573 | 720 | 13.6 | 12.7 | May 8, 2025 | J-GAAP |
| Apr - Jun, 2025 | 12,341 | 1,676 | 1,709 | 1,073 | 20.2 | 13.6 | Aug 6, 2025 | J-GAAP |
| Jul - Sep, 2025 | 14,263 | 2,768 | 2,676 | 1,772 | 33.4 | 19.4 | Nov 5, 2025 | J-GAAP |
| Oct - Dec, 2025 | 14,107 | 2,547 | 2,524 | 1,667 | 31.4 | 18.1 | Feb 4, 2026 | J-GAAP |
| YoY | +3.6% | +0.1% | +0.3% | -3.0% | -2.9% |
Related Articles
The Minami-Nippon Bank, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 2%, Exceeds Full-Year Plan
TOBU RAILWAY, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 3%, Dividend Revised Upward by 2.5 Yen
ORGANO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 32%, Oct-Dec Ordinary Profit Increases by 11%
YAMAHA, Net Income Forecast for the Fiscal Year Revised Upward by 4%
WAKAMOTO PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Turns to Profit
Astellas Pharma, Net Income Forecast for the Fiscal Year Revised Upward by 39%, Highest in Seven Terms
TAKACHIHO KOHEKI , Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%
NISHIO HOLDINGS, Oct-Dec (1Q) Ordinary Profit Decreases by 8%
ELAN, 20% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 1 Yen
M3 Inc, Apr-Dec (Cumulative 3Q) Net Income Increases by 28%, Oct-Dec Net Income Increases by 24%